Skip to main content
. 2007 Oct 31;1(1):e67. doi: 10.1371/journal.pntd.0000067

Table 3. Country Background Information.

Country Total Population (millions)a Estimated Population At-Risk for LF (millions) Drugs Used Areas Included in Cost Analysis Drug Distribution Strategy
Burkina Faso 12.62 12.62 Mectizan albendazole 2001: Gaoua Region NPELF is integrated in the health system. House-to-house by volunteers
2002: Gaoua, Tenkodogo, Koudougou (2 of 5 districts) and Manga Regions
Dominican Republic 8.62 1.5 DEC albendazole 2002–2003: Southwest area Year 1: community distribution (house to house)
Year 2: partial integration with primary health care system (house to house)
Egypt 70.51 2.57 DEC albendazole 2000: Qalyubia, Menofia, Sharkia, K. El Sheikh, Dakahlia, Gharbia, Giza, Governorates House-to-house by teams of doctors and nurses
2001: same plus Assiut Governorate
Ghana 20.47 6.02 Mectizan 2003: Ahanta West, Builsa and Lawra Districts Distribution posts, house-to-house or combination of two by volunteers
albendazole
Haiti 8.22 6 DEC 2000–2003: Leogane Distribution posts by program staff
albendazole 2002: Milot
Philippines 78.58 23.5 DEC 2003: Sorsogon Province Distribution posts, house-to-house by volunteers
albendazole
Tanzania 35.23 31.17 Mectizan 2000: Mafia District First at distribution posts, then house-to-house follow-up by health care workers and volunteers
albendazole 2001: Mafia and Mkuranga Districts
2002: Mafia, Mkuranga, Masasi Districts
2003: Mafia, Mkuranga, Masasi and Kilwa Districts
a

(World Health Organization 2002, World Health Organization 2003, World Health Organization 2004a).